446 related articles for article (PubMed ID: 32132239)
1. Mutations Near the N Terminus of Vaccinia Virus G9 Protein Overcome Restrictions on Cell Entry and Syncytium Formation Imposed by the A56/K2 Fusion Regulatory Complex.
Cotter CA; Moss B
J Virol; 2020 May; 94(10):. PubMed ID: 32132239
[TBL] [Abstract][Full Text] [Related]
2. Experimental Evolution To Isolate Vaccinia Virus Adaptive G9 Mutants That Overcome Membrane Fusion Inhibition via the Vaccinia Virus A56/K2 Protein Complex.
Hong GC; Tsai CH; Chang W
J Virol; 2020 May; 94(10):. PubMed ID: 32132237
[TBL] [Abstract][Full Text] [Related]
3. Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex.
Wagenaar TR; Ojeda S; Moss B
J Virol; 2008 Jun; 82(11):5153-60. PubMed ID: 18353946
[TBL] [Abstract][Full Text] [Related]
4. Vaccinia mature virus fusion regulator A26 protein binds to A16 and G9 proteins of the viral entry fusion complex and dissociates from mature virions at low pH.
Chang SJ; Shih AC; Tang YL; Chang W
J Virol; 2012 Apr; 86(7):3809-18. PubMed ID: 22278246
[TBL] [Abstract][Full Text] [Related]
5. Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex.
Wagenaar TR; Moss B
J Virol; 2007 Jun; 81(12):6286-93. PubMed ID: 17409143
[TBL] [Abstract][Full Text] [Related]
6. Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion.
Wagenaar TR; Moss B
J Virol; 2009 Feb; 83(4):1546-54. PubMed ID: 19036815
[TBL] [Abstract][Full Text] [Related]
7. A novel mode of poxvirus superinfection exclusion that prevents fusion of the lipid bilayers of viral and cellular membranes.
Laliberte JP; Moss B
J Virol; 2014 Sep; 88(17):9751-68. PubMed ID: 24920806
[TBL] [Abstract][Full Text] [Related]
8. Insights into the Organization of the Poxvirus Multicomponent Entry-Fusion Complex from Proximity Analyses in Living Infected Cells.
Schin AM; Diesterbeck US; Moss B
J Virol; 2021 Jul; 95(16):e0085221. PubMed ID: 34076488
[TBL] [Abstract][Full Text] [Related]
9. The myristate moiety and amino terminus of vaccinia virus l1 constitute a bipartite functional region needed for entry.
Foo CH; Whitbeck JC; Ponce-de-León M; Saw WT; Cohen GH; Eisenberg RJ
J Virol; 2012 May; 86(10):5437-51. PubMed ID: 22398293
[TBL] [Abstract][Full Text] [Related]
10. Loss of the vaccinia virus 35-amino acid hydrophobic O3 protein is partially compensated by mutations in the transmembrane domains of other entry proteins.
Tak AI; Americo JL; Diesterbeck US; Moss B
J Virol; 2021 Mar; 95(8):. PubMed ID: 33504600
[TBL] [Abstract][Full Text] [Related]
11. Sequence-divergent chordopoxvirus homologs of the o3 protein maintain functional interactions with components of the vaccinia virus entry-fusion complex.
Satheshkumar PS; Moss B
J Virol; 2012 Feb; 86(3):1696-705. PubMed ID: 22114343
[TBL] [Abstract][Full Text] [Related]
12. Vaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complex.
Ojeda S; Domi A; Moss B
J Virol; 2006 Oct; 80(19):9822-30. PubMed ID: 16973586
[TBL] [Abstract][Full Text] [Related]
13. Protein B5 is required on extracellular enveloped vaccinia virus for repulsion of superinfecting virions.
Doceul V; Hollinshead M; Breiman A; Laval K; Smith GL
J Gen Virol; 2012 Sep; 93(Pt 9):1876-1886. PubMed ID: 22622330
[TBL] [Abstract][Full Text] [Related]
14. The vaccinia virus fusion inhibitor proteins SPI-3 (K2) and HA (A56) expressed by infected cells reduce the entry of superinfecting virus.
Turner PC; Moyer RW
Virology; 2008 Oct; 380(2):226-33. PubMed ID: 18760436
[TBL] [Abstract][Full Text] [Related]
15. Membrane fusion during poxvirus entry.
Moss B
Semin Cell Dev Biol; 2016 Dec; 60():89-96. PubMed ID: 27423915
[TBL] [Abstract][Full Text] [Related]
16. Vaccinia Virus Phospholipase Protein F13 Promotes Rapid Entry of Extracellular Virions into Cells.
Bryk P; Brewer MG; Ward BM
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540596
[TBL] [Abstract][Full Text] [Related]
17. Vaccinia virus l1 protein is required for cell entry and membrane fusion.
Bisht H; Weisberg AS; Moss B
J Virol; 2008 Sep; 82(17):8687-94. PubMed ID: 18596103
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entry.
Priyamvada L; Kallemeijn WW; Faronato M; Wilkins K; Goldsmith CS; Cotter CA; Ojeda S; Solari R; Moss B; Tate EW; Satheshkumar PS
PLoS Pathog; 2022 Oct; 18(10):e1010662. PubMed ID: 36215331
[TBL] [Abstract][Full Text] [Related]
19. RNA Polymerase Mutations Selected during Experimental Evolution Enhance Replication of a Hybrid Vaccinia Virus with an Intermediate Transcription Factor Subunit Replaced by the Myxoma Virus Ortholog.
Stuart CA; Zhivkoplias EK; Senkevich TG; Wyatt LS; Moss B
J Virol; 2018 Oct; 92(20):. PubMed ID: 30045995
[TBL] [Abstract][Full Text] [Related]
20. Deletion of the Vaccinia Virus I2 Protein Interrupts Virion Morphogenesis, Leading to Retention of the Scaffold Protein and Mislocalization of Membrane-Associated Entry Proteins.
Hyun SI; Weisberg A; Moss B
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
